[1] Falk E. Pathogenesis of Atherosclerosis[J]. J Am Col Cardiol, 2006, 47(8 Suppl): C7-12. [2] Quinones MJ, Nicholas SB, Lyon CJ. Insulin resistance and the endothelium[J]. Curr Diab Rep, 2005, 5(4): 246-253. [3] Ross R. Atheroscleros-an inflammatory disease[J]. N Engl J Med, 1999, 340(2):115-126. [4] Hulsmans M, Holvoet P. The cicious circle between oxidative stress and inflammation in atherosclerosis[J]. J Cell Mol Med, 2010,14(1/2):70-78. [5] Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice[J]. J Am Coll Cardiol, 2009, 54(23): 2129-2138. [6] Lien E,Means TK, Heine H, et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide[J]. J Clin Invest, 2000, 105 (4): 497-504. [7] Yang QW, Mou L, Lv FL, et al. Role of Toll-like receptor 4/NF-kappaB pathway in monocyte-endothelial adhesion induced by low shear stress and ox-LDL[J]. Biorheology, 2005, 42(3):225-236. [8] Ishikado A, Nishio Y, Yamane K, et al. Soy phosphatidylcholine inhibited TLR4-mediated MCP-1 expression in vascular cells[J]. Atherosclerosis, 2009, 205(2):404-412. [9] 杜健鹏,陈泽涛.益气活血法改善微循环的实验研究[J].中国实验方剂学杂志,2006,12(9): 31-35. [10] 王艳蕾,景优玲,李宏杰,等.黄芪注射液对兔肠系膜上动脉闭塞性休克脂质过氧化损伤的防治及其机制[J].世界华人消化杂志,2008,16(18):2040-2044. [11] Ryu M, Kim EH, Chun M, et al. Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitnat with attenuation of p38 and Erk[J]. J Ethnopharmacol, 2008, 115(2):184-193. [12] Friendland JS. Cheokines and human infection[J]. Clin Sci,1995,88:393-400. [13] Bryant CE, Spring DR, Gangloff M, et al. The molecular vasis of the host response to lipopolsaccharide[J]. Nat Rev Microbiol, 2010, 8(1):8-14. [14] Ji Y, Liu J, Wang Z, et al. Angiotensin Ⅱ induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells[J]. Cell Physiol Biochem, 2009, 23(4/5/6):265-276. |